KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Restructuring: 2022-2025

Historic Cash from Restructuring for Hims & Hers Health (HIMS) over the last 3 years, with Sep 2025 value amounting to $2.0 million.

  • Hims & Hers Health's Cash from Restructuring was N/A to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2023, which is 221.51% up from last year.
  • Per Hims & Hers Health's latest filing, its Cash from Restructuring stood at $2.0 million for Q3 2025, which was up 1.07% from $2.0 million recorded in Q2 2025.
  • Hims & Hers Health's 5-year Cash from Restructuring high stood at $2.0 million for Q3 2025, and its period low was -$256,000 during Q3 2022.
  • Over the past 2 years, Hims & Hers Health's median Cash from Restructuring value was $1.0 million (recorded in 2025), while the average stood at $1.1 million.
  • Within the past 5 years, the most significant YoY rise in Hims & Hers Health's Cash from Restructuring was 4,645.45% (2023), while the steepest drop was 58.74% (2023).
  • Hims & Hers Health's Cash from Restructuring (Quarterly) stood at $1.0 million in 2022, then tumbled by 58.74% to $427,000 in 2023, then reached $2.0 million in 2025.
  • Its Cash from Restructuring stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.0 million for Q1 2025.